Find winning stocks in any market cycle. Join 7 million investors using Simply Wall St's investing ideas for FREE. DexCom (NasdaqGS:DXCM) is seeing higher adoption of its continuous glucose monitoring ...
DexCom Inc. (NASDAQ:DXCM) is one of the best medical technology stocks to invest in. On February 12, DexCom Inc. (NASDAQ:DXCM) shared its Q4 2025 earnings and reported $1.26 billion in quarterly ...
Jefferies analyst Matthew Taylor reiterated a Buy rating on Dexcom today and set a price target of $112.00. According to TipRanks, Taylor is a 4-star analyst with an average return of 7.5% and a 55.13 ...
In a report released today, Patrick Wood from Morgan Stanley maintained a Buy rating on Dexcom, with a price target of $75.00. According to TipRanks, Wood is an analyst with an average return of -1.2% ...
In February 2026, DexCom reported fourth-quarter 2025 sales of US$1,259.6 million and full-year 2025 sales of US$4,662 million, with net income rising to US$267.3 million for the quarter and US$836.3 ...
A labeling mix-up involving a popular honey barbecue sauce has triggered a nationwide recall due to undeclared allergens that could pose serious health risks. Savannah Bee Company announced on Friday, ...